General Information of This Metabolic Reaction (MR) (ID:
MR001405) |
Formula |
|
Reactant |
Lamivudine diphosphate |
Product |
Lamivudine triphosphate |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Phosphoglycerate kinase 2 (PGK2)
|
DME Info
|
Nucleoside diphosphate kinase (NME4)
|
DME Info
|
Metabolic Type
|
Other reaction
-
Phosphorylation
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Produce The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Metabolize The Produtc of This MR
|
|
References |
1 |
Model for intracellular Lamivudine metabolism in peripheral blood mononuclear cells ex vivo and in human immunodeficiency virus type 1-infected adolescents. Antimicrob Agents Chemother. 2006 Aug;50(8):2686-94.
|
2 |
Antiviral and cellular metabolism interactions between Dexelvucitabine and lamivudine Antimicrob Agents Chemother. 2007 Jun;51(6):2130-5. doi: 10.1128/AAC.01543-06.
|
3 |
An open-label, randomized, single intravenous dosing study to investigate the effect of fixed-dose combinations of tenofovir/lamivudine or atazanavir/ritonavir on the pharmacokinetics of remdesivir in Ugandan healthy volunteers (RemTLAR). Trials. 2021 Nov 23;22(1):831. doi: 10.1186/s13063-021-05752-1.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.